Thomas J. Weber, MD, Program Co-Chair
Professor of Medicine
Division of Endocrinology,
Metabolism, and Nutrition
Duke University Medical Center
Deepika Reddy, MD, Program Co-Chair
Associate Professor
Division of Diabetes, Endocrinology, and Metabolism
University of Utah Healthcare
Bradley D. Anawalt, MD
Chief of Medicine
Vice Chair Department of Medicine
Professor, General Internal Medicine
University of Washington School of Medicine
Danit Ariel, MD, MS
Associate Professor of Medicine
Division of Endocrinology, Gerontology, and Metabolism
Stanford University School of Medicine
Palak Choksi, MD
Associate Professor, Medicine
Department of Endocrinology/Metabolism/Diabetes
University of Colorado Denver
Erik A. Imel, MD
Professor of Medicine and Pediatrics
Indiana University School of Medicine
Adriana G. Ioachimescu, MD, PhD
Professor of Medicine
Endocrinology and Molecular Medicine Division
Medical College of Wisconsin
Akshay Jain, MD
Clinical Instructor
University of British Columbia
TLC Diabetes and Endocrinology
Angela M. Leung, MD, MSc
Associate Professor of Medicine
UCLA David Geffen School of Medicine
VA Greater Los Angeles Healthcare System
Sarah E. Mayson, MD
Associate Professor of Medicine
Director of the Endocrinology
Fellowship Program
Division of Endocrinology, Metabolism, and Diabetes
University of Colorado School of Medicine
Kevin M. Pantalone, DO
Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Staff Endocrinologist
Director of Diabetes Initiatives
Department of Endocrinology
Cleveland Clinic
Aled Rees, PhD, MB BCh
Professor of Endocrinology
Neuroscience and Mental Health Innovation Institute
Cardiff University
Meera Shah, MB ChB
Assistant Professor of Medicine
Mayo Clinic College of Medicine
Consultant, Division of Endocrinology
Mayo Clinic – Rochester
Anu Sharma, MBBS
Assistant Professor of Medicine
Division of Endocrinology, Diabetes, and Metabolism
University of Florida
Vinaya Simha, MBBS, MD
Associate Professor of Medicine
Mayo Clinic College of Medicine
Mayo Clinic – Rochester
Elias Spanakis, MD
Associate Professor of Medicine
University of Maryland School of Medicine
Adina F. Turcu, MD, MS
Associate Professor of Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan
Abbie L. Young, MS, CGC, ELS(D)
Medical Editor
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s ESAP Faculty Working Group.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The following faculty reported relevant financial relationship(s): Bradley D. Anawalt, MD is a consultant for Biozen. Adriana Ioachimescu, MD, PhD, is a consultant for Crinetics, Xeris, and Camurus and has served as principal investigator for institution-directed research grants from Recodati. Erik Imel, MD, is a clinical trial investigator for Ultragenyx, Alexion, Amgen, Amolyt, Kyowa Kirin, Calciolytix, Spruce, Neurocrine, and Sanofi. He serves on advisory boards for Ultragenyx, Kyowa Kirin and Neurocrine. He is also a consultant for Novo Nordisk and serves on a Data and Safety Monitoring Board for Inozyme and Agios, and AshiBio. Akshay Jain, MD, has served on an advisory board for Abbott, Amgen, Novo Nordisk, AstraZeneca, Bausch Healthcare, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, Embecta, GSK, HLS Therapeutics, Janssen, Medtronic, Novartis, Gilead Sciences, PocketPills, Insulet, Roche, Takeda, and Ypsomed. He has served as a speaker for Abbott, Amgen, Novo Nordisk, AstraZeneca, Bausch Healthcare, Bayer, Boehringer Ingelheim, Care to Know, CCRN, Dexcom, Diabetes Canada, Eli Lilly, Embecta, EOCI, GSK, HLS Therapeutics, Janssen, Liv, MDBriefcase, Medtronic, Moderna, Novartis, and Pfizer. He has also been a clinical researcher for Abbott, Amgen, and Novo Nordisk. Kevin M. Pantalone, DO, receives research support from Bayer, Novo Nordisk, and Twin Health. He is a speaker for AstraZeneca, Corcept Therapeutics, and Novo Nordisk. He is a consultant to Bayer, Boehringer Ingelheim, Corcept Therapeutics, Diasome, Eli Lilly, Merck, Novo Nordisk, and Sanofi. He is a principal investigator for Eli Lilly, Novo Nordisk, and Twin Health. Aled Rees, PhD, MB BCh, is a principal investigator for Ascendis, Diurnal Ltd, Neurocrine Biosciences, Sparrow Pharmaceuticals. He is also a speaker for Diurnal Ltd. Vinaya Simha, MD, serves on an advisory board for Pfizer. Elias Spanakis, MD, received research support from Dexcom and Tandem Diabetes, both of which were provided to Baltimore VA Medical Center and University of Maryland Adina Turcu, MD, MS, receives research funds from the National Institutes of Health. She is an institutional clinical trial investigator for Astra Zeneca. Thomas J. Weber, MD, serves as a primary investigator and consultant for Ultragenyx. He is on the FDA Endocrine and Metabolic Drug Advisory Committee.
The following faculty reported no relevant financial relationships: Danit Ariel, MD, MS; Palak Choksi, MD; Angela Leung, MD, MSc; Sarah Mayson, MD; Deepika Reddy, MD; Meera Shah, MB ChB, and Anu Sharma, MBBS.
The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.
The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is not supported by educational grant(s) or other funds from any commercial supporter.